StockData

Zhengye Biotechnology Holding Ltd (ZYBT) stock

ZYBTNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$1.50−0.02 (-1.32%)

Close on Nov 18, 2026Market cap $71.09MP/E –Yield –

Zhengye Biotechnology revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was CN¥116.36M, down 37.6% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025CN¥116.36M-37.6%
FY2024Dec 31, 2024CN¥186.36M-12.0%
FY2023Dec 31, 2023CN¥211.65M-18.7%
FY2022Dec 31, 2022CN¥260.27M–

More Zhengye Biotechnology figures

See a number that looks wrong?